Clinical Trial: Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title:

Brief Summary:

OBJECTIVES: I. Provide curative immunoreconstituting allogeneic bone marrow transplantation for patients with primary immunodeficiencies.

II. Determine relevant outcomes of this treatment in these patients including quality of survival, extent of morbidity and mortality from complications of the treatment (e.g., graft versus host disease, regimen related toxicities, B- cell lymphoproliferative disease), and completeness of functional immunoreconstitution.